b.wojcik
Submits third-party assay reports on material purchased directly. Based in Izmir.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.79%
n=7
Suppliers covered
6
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041975 | Humanin (HNG) | TFC | TFC-2605-U5564 | Nordanalyt | 2026-Q3 | 99.93 | 6.86 | 91.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043500 | BPC-157 | BCH | BCH-2603-G6422 | VendorInvestigate | 2026-Q3 | 97.86 | 4.82 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-043570 | Tirzepatide | BCH | BCH-2601-N7656 | Janoshik | 2026-Q1 | 97.62 | 3.49 | 103.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020790 | Semaglutide | SGN | SGN-2502-J9961 | Kestrel | 2025-Q2 | 98.79 | 4.46 | — | Supplier-supplied | 2 | FAIL |
| AX-2024-004511 | Ipamorelin | FGP | FGP-2402-D2141 | Janoshik | 2024-Q3 | 99.90 | 5.09 | 90.4 | Laboratory-retained | 0 | PASS |
| AX-2024-005076 | Semaglutide | MKM | MKM-2403-C3618 | Kestrel | 2024-Q2 | 99.57 | 5.71 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2024-004320 | Retatrutide | QYB | QYB-2312-K5632 | Janoshik | 2024-Q2 | 98.74 | 5.29 | 95.6 | Supplier-supplied | 4 | MARGINAL |